Terms: = Breast cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
10476 results:
1. Metochalcone induces senescence-associated secretory phenotype via JAK2/STAT3 pathway in breast cancer.
Zhou J; Wan F; Xiao B; Li X; Peng C; Peng FU
Oncol Res; 2024; 32(5):943-953. PubMed ID: 38686052
[TBL] [Abstract] [Full Text] [Related]
2. Cytotoxic and apoptotic effects of Ferula gummosa Boiss: extract on human breast adenocarcinoma cell line.
Rashidi R; Roohbakhsh A; Mohtashami L; Mobasheri L; Kheradmand H; Amiri MS; Ghorbani A; Mousavi SH
Mol Biol Rep; 2024 Apr; 51(1):592. PubMed ID: 38683376
[TBL] [Abstract] [Full Text] [Related]
3. Novel Withanolides from
Huang L; Wei Y; Ni M; Hu H; Xi L; Wang C; Zhu Z; Yang B; Zhao H
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675657
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
[TBL] [Abstract] [Full Text] [Related]
5. Synthesis, bioactivity assessment, molecular docking and ADMET studies of new chromone congeners exhibiting potent anticancer activity.
Abo-Salem HM; El Souda SSM; Shafey HI; Zoheir KMA; Ahmed KM; Mahmoud K; Mahrous KF; Fawzy NM
Sci Rep; 2024 Apr; 14(1):9636. PubMed ID: 38671055
[TBL] [Abstract] [Full Text] [Related]
6. Inflammatory breast cancer: An overview about the histo-pathological aspect and diagnosis.
Sahraoui G; Rahoui N; Driss M; Mrad K
Int Rev Cell Mol Biol; 2024; 384():47-61. PubMed ID: 38637099
[TBL] [Abstract] [Full Text] [Related]
7. Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of breast cancer-Associated Germline Pathogenic Variants in Mexico.
Mesa-Chavez F; Chavarri-Guerra Y; Aguilar-Y-Mendez D; Becerril-Gaitan A; Vaca-Cartagena BF; Carrillo-Bedoya A; Santiesteban-González S; Aranda-Gutierrez A; Rodríguez-Faure A; Obregon-Leal D; Quintero-Beuló G; Rodriguez-Olivares JL; Miaja M; Weitzel JN; Villarreal-Garza C
JCO Glob Oncol; 2024 Apr; 10():e2300417. PubMed ID: 38635940
[TBL] [Abstract] [Full Text] [Related]
8. Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic breast cancer Treated With Abemaciclib: Data From the SCRUM-Japan cancer Genome Screening Project.
Hattori M; Serelli-Lee V; Naito Y; Yamanaka T; Yasojima H; Nakamura R; Fujisawa T; Imai M; Nakamura Y; Bando H; Kawaguchi T; Yoshino T; Iwata H
JCO Precis Oncol; 2024 Apr; 8():e2300647. PubMed ID: 38635933
[TBL] [Abstract] [Full Text] [Related]
9. Dysregulated Ribosome Biogenesis Is a Targetable Vulnerability in Triple-Negative breast cancer: MRPS27 as a Key Mediator of the Stemness-inhibitory Effect of Lovastatin.
Zheng C; Yao H; Lu L; Li H; Zhou L; He X; Xu X; Xia H; Ding S; Yang Y; Wang X; Wu M; Xue L; Chen S; Peng X; Cheng Z; Wang Y; He G; Fu S; Keller ET; Liu S; Jiang YZ; Deng X
Int J Biol Sci; 2024; 20(6):2130-2148. PubMed ID: 38617541
[TBL] [Abstract] [Full Text] [Related]
10. The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in breast cancer: A Randomized Clinical Study.
Faur IF; Dobrescu A; Clim IA; Pasca P; Prodan-Barbulescu C; Tarta C; Neamtu AA; Brebu D; Neamtu C; Rosu M; Duta C; Clim A; Lazar G; Totolici B
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612725
[TBL] [Abstract] [Full Text] [Related]
11. Hinokitiol Inhibits breast cancer Cells In Vitro Stemness-Progression and Self-Renewal with Apoptosis and Autophagy Modulation via the CD44/Nanog/SOX2/Oct4 Pathway.
Chiang YF; Huang KC; Chen HY; Hamdy NM; Huang TC; Chang HY; Shieh TM; Huang YJ; Hsia SM
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612715
[TBL] [Abstract] [Full Text] [Related]
12. ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway.
Zhou X; Zhao J; Yan T; Ye D; Wang Y; Zhou B; Liu D; Wang X; Zheng W; Zheng B; Qian F; Li Y; Li D; Fang L
Cell Death Dis; 2024 Apr; 15(4):260. PubMed ID: 38609357
[TBL] [Abstract] [Full Text] [Related]
13. Active substance and mechanisms of Actinidia chinensis Planch for the treatment of breast cancer was explored based on network pharmacology and in silico study.
Xu Y; Yang J; Han X; Gan C; Wei X
Medicine (Baltimore); 2024 Apr; 103(15):e37829. PubMed ID: 38608062
[TBL] [Abstract] [Full Text] [Related]
14. Genetic interactions reveal distinct biological and therapeutic implications in breast cancer.
Lin CJ; Jin X; Ma D; Chen C; Ou-Yang Y; Pei YC; Zhou CZ; Qu FL; Wang YJ; Liu CL; Fan L; Hu X; Shao ZM; Jiang YZ
Cancer Cell; 2024 Apr; 42(4):701-719.e12. PubMed ID: 38593782
[TBL] [Abstract] [Full Text] [Related]
15. MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative breast cancer.
Zheng SM; Feng YC; Zhu Q; Li RQ; Yan QQ; Teng L; Yue YM; Han MM; Ye K; Zhang SN; Qi TF; Tang CX; Zhao XH; Zhang YY; Xu L; Xu R; Xing J; Baker M; Liu T; Thorne RF; Jin L; Preiss T; Zhang XD; Cang S; Gao JN
Cancer Res; 2024 May; 84(9):1460-1474. PubMed ID: 38593213
[TBL] [Abstract] [Full Text] [Related]
16. Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer.
Wang Y; Li Y; Jing Y; Yang Y; Wang H; Ismtula D; Guo C
Sci Rep; 2024 Apr; 14(1):8201. PubMed ID: 38589634
[TBL] [Abstract] [Full Text] [Related]
17. Comprehensive bioinformatics analysis unveils THEMIS2 as a carcinogenic indicator related to immune infiltration and prognosis of thyroid cancer.
Liu JF; Zou B; Xiang C; Yan HC
Sci Rep; 2024 Apr; 14(1):8156. PubMed ID: 38589421
[TBL] [Abstract] [Full Text] [Related]
18. HPLC-ESI/MS-MS metabolic profiling of white pitaya fruit and cytotoxic potential against cervical cancer: Comparative studies, synergistic effects, and molecular mechanistic approaches.
El-Nashar HAS; Al-Azzawi MA; Al-Kazzaz HH; Alghanimi YK; Kocaebli SM; Alhmammi M; Asad A; Salam T; El-Shazly M; Ali MAM
J Pharm Biomed Anal; 2024 Jul; 244():116121. PubMed ID: 38581932
[TBL] [Abstract] [Full Text] [Related]
19. Discovery of ganoderic acid A (GAA) PROTACs as MDM2 protein degraders for the treatment of breast cancer.
Li Y; Li G; Zuo C; Wang X; Han F; Jia Y; Shang H; Tian Y
Eur J Med Chem; 2024 Apr; 270():116367. PubMed ID: 38581732
[TBL] [Abstract] [Full Text] [Related]
20. Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer.
Kim YN; Chung YS; Park E; Lee ST; Lee JY
Sci Rep; 2024 Apr; 14(1):7992. PubMed ID: 38580676
[TBL] [Abstract] [Full Text] [Related]
[Next]
